More about
Hrr-Positive Disease
News
August 22, 2024
2 min read
Save
Olaparib monotherapy ‘true paradigm shift’ in biochemically recurrent prostate cancer
Olaparib monotherapy may be an effective treatment option for certain men with biochemically recurrent prostate cancer, according to results of a nonrandomized phase 2 trial.